Anti-VEGF Therapy to Limit DR Progression

[ad_1]
Dr. Ciulla recently authored a review on a new indication for Lucentis and Eylea, which have been shown to slow the progression of diabetic retinopathy…

Anti-VEGF Therapy to Limit DR Progression

Although many questions remain, anti-VEGF therapies for diabetic retinopathy treatment will dramatically alter the delivery of care.
[ad_2]

Return to main website.